Hemolysis Clinical Trials

7 recruitingLast updated: May 11, 2026

There are 7 actively recruiting hemolysis clinical trials across 6 countries. Studies span Not Applicable, Phase 3. Top locations include Dokki, Giza Governorate, Egypt, Aurora, Colorado, United States, Boston, Massachusetts, United States. Updated daily from ClinicalTrials.gov.


Hemolysis Trials at a Glance

7 actively recruiting trials for hemolysis are listed on ClinicalTrialsFinder across 6 cities in 6 countries. The largest study group is Not Applicable with 4 trials, with the heaviest enrollment activity in Dokki, Aurora, and Boston. Lead sponsors running hemolysis studies include Cairo University, Alexion Pharmaceuticals, Inc., and Aswan University.

Browse hemolysis trials by phase

About Hemolysis Clinical Trials

Looking for clinical trials for Hemolysis? There are currently 5 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Hemolysis trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Hemolysis clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 17 of 7 trials

Recruiting
Not Applicable

Comparison of Efficacy and Safety of Manual Syringing Versus Pneumatic Pressure Bag for Blood Transfusion in Patients Undergoing Cesarean Section With Major Obstetric Hemorrhage

Obstetric HemostasisIntravascular HemolysisMajor Obstetric Hemorrhage+2 more
Aswan University50 enrolled1 locationNCT07466719
Recruiting

Feasibility Performance Study of ABL90 FLEX PLUS HEM

Hemolysis
Radiometer Medical ApS95 enrolled1 locationNCT07345091
Recruiting

Modeling Blood Management and Hemolytic Risk in Pediatric Heart Surgery

blood transfusionHeart SurgeryHemolysis
Boston Children's Hospital50 enrolled1 locationNCT06721455
Recruiting
Phase 3

Study of Danicopan as Add-on Treatment to Ravulizumab or Eculizumab in Pediatric Participants With PNH Who Have Clinically Significant Extravascular Hemolysis

PNHExtravascular HemolysisParoxysmal nocturnal hemoglobinuria
Alexion Pharmaceuticals, Inc.6 enrolled4 locationsNCT06449001
Recruiting
Not Applicable

Optimizing Pulsatility During Cardiopulmonary Bypass to Reduce Acute Kidney Injury

SurgeryThrombocytopeniaAcute Kidney Injury+1 more
University of Colorado, Denver1,100 enrolled1 locationNCT06349577
Recruiting
Not Applicable

Ventilatory Functions and Physical Intolerance in ESRD Adolescents: Response to Program of Walking With Dogs

End Stage Renal DiseaseHemolysis
Cairo University40 enrolled1 locationNCT06861816
Recruiting
Not Applicable

Restless Leg Syndrome: Is There a Response to Buddhist Walking Meditation in Hemodialysis

Restless Legs SyndromeHemolysis
Cairo University40 enrolled1 locationNCT06806891